Otitis Media Practice During the COVID-19 Pandemic.

COVID-19 acute otitis media admission burden analysis coronavirus infection mastoiditis otitis media otitis media with effusion

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2021
Historique:
received: 30 07 2021
accepted: 07 12 2021
entrez: 24 1 2022
pubmed: 25 1 2022
medline: 28 1 2022
Statut: epublish

Résumé

The global coronavirus disease-2019 (COVID-19) pandemic has changed the prevalence and management of many pediatric infectious diseases, including acute otitis media (AOM). Coronaviruses are a group of RNA viruses that cause respiratory tract infections in humans. Before the COVID-19 pandemic, coronavirus serotypes OC43, 229E, HKU1, and NL63 were infrequently detected in middle ear fluid (MEF) specimens and nasopharyngeal aspirates in children with AOM during the 1990s and 2000s and were associated with a mild course of the disease. At times when CoV was detected in OM cases, the overall viral load was relatively low. The new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative pathogen responsible for the eruption of the COVID-19 global pandemic. Following the pandemic declaration in many countries and by the World Health Organization in March 2020, preventive proactive measures were imposed to limit COVID-19. These included social distancing; lockdowns; closure of workplaces; kindergartens and schools; increased hygiene; use of antiseptics and alcohol-based gels; frequent temperature measurements and wearing masks. These measures were not the only ones taken, as hospitals and clinics tried to minimize treating non-urgent medical referrals such as OM, and elective surgical procedures were canceled, such as ventilating tube insertion (VTI). These changes and regulations altered the way OM is practiced during the COVID-19 pandemic. Advents in technology allowed a vast use of telemedicine technologies for OM, however, the accuracy of AOM diagnosis in those encounters was in doubt, and antibiotic prescription rates were still reported to be high. There was an overall decrease in AOM episodes and admissions rates and with high spontaneous resolution rates of MEF in children, and a reduction in VTI surgeries. Despite an initial fear regarding viral shedding during myringotomy, the procedure was shown to be safe. Special draping techniques for otologic surgery were suggested. Other aspects of OM practice included the presentation of adult patients with AOM who tested positive for SARS-2-CoV and its detection in MEF samples in living patients and in the mucosa of the middle ear and mastoid in post-mortem specimens.

Identifiants

pubmed: 35071032
doi: 10.3389/fcimb.2021.749911
pmc: PMC8777025
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

749911

Informations de copyright

Copyright © 2022 Marom, Pitaro, Shah, Torretta, Marchisio, Kumar, Barth and Tamir.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Laryngol Otol. 2021 Mar;135(3):273-275
pubmed: 33517922
J Med Virol. 2011 Nov;83(11):2008-17
pubmed: 21915878
Emerg Infect Dis. 2005 Aug;11(8):1225-9
pubmed: 16102311
Eur Ann Otorhinolaryngol Head Neck Dis. 2020 May;137(3):177-181
pubmed: 32312676
Eur Arch Otorhinolaryngol. 2021 Nov 22;:
pubmed: 34807284
Otolaryngol Head Neck Surg. 2020 Jul;163(1):91-93
pubmed: 32366178
Int J Pediatr Otorhinolaryngol. 2021 Aug;147:110785
pubmed: 34116322
Otol Neurotol. 2021 Mar 1;42(3):e378-e379
pubmed: 33122504
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4733-4741
pubmed: 33486567
Otolaryngol Head Neck Surg. 2020 Aug;163(2):320-324
pubmed: 32423287
Telemed J E Health. 2014 Dec;20(12):1121-6
pubmed: 25290233
Otol Neurotol. 2020 Oct;41(9):1163-1174
pubmed: 32925832
Arch Dis Child. 2021 Feb;106(2):e5
pubmed: 32554509
Otolaryngol Clin North Am. 2021 Feb;54(1):11-23
pubmed: 33243372
Otolaryngol Head Neck Surg. 2021 Nov;165(5):710-715
pubmed: 33494659
J Laryngol Otol. 2021 Jan;135(1):10-13
pubmed: 33407978
Am J Epidemiol. 1986 May;123(5):862-8
pubmed: 3008551
Swiss Med Wkly. 2021 Oct 18;151:w30068
pubmed: 34668689
J Otolaryngol Head Neck Surg. 2020 Oct 6;49(1):71
pubmed: 33023663
Paediatr Child Health. 2016 Jan-Feb;21(1):39-50
pubmed: 26941560
Nat Rev Drug Discov. 2016 May;15(5):327-47
pubmed: 26868298
Pediatrics. 1998 Aug;102(2 Pt 1):291-5
pubmed: 9685428
Int J Pediatr Otorhinolaryngol. 2021 Jun;145:110714
pubmed: 33894522
Am Rev Respir Dis. 1974 Jun;109(6):621-4
pubmed: 4365165
Laryngoscope. 2020 Nov;130(11):2693-2699
pubmed: 32720316
Ear Nose Throat J. 2021 Mar 26;:1455613211005113
pubmed: 33765854
Epidemiol Health. 2020;42:e2020013
pubmed: 32192278
Otol Neurotol. 2021 Feb 1;42(2):346-347
pubmed: 33122505
Indian J Otolaryngol Head Neck Surg. 2020 Jul 22;:1-3
pubmed: 32837940
N Engl J Med. 2003 May 15;348(20):1967-76
pubmed: 12690091
Pediatrics. 2021 Apr;147(4):
pubmed: 33361360
Eur J Pediatr. 2021 Feb;180(2):649-652
pubmed: 32691131
Pediatr Infect Dis J. 2020 Dec;39(12):e449-e452
pubmed: 33031142
Pediatr Infect Dis J. 2012 Nov;31(11):1128-34
pubmed: 22668804
Infection. 1980;8(2):70-2
pubmed: 6248465
Pediatrics. 1999 Apr;103(4 Pt 1):711-8
pubmed: 10103291
Otolaryngol Head Neck Surg. 2021 Oct;165(4):532-535
pubmed: 33557705
World J Otorhinolaryngol Head Neck Surg. 2021 Jan 22;:
pubmed: 33520334
Otolaryngol Head Neck Surg. 2020 Jun;162(6):797-799
pubmed: 32286916
Antibiotics (Basel). 2021 Feb 18;10(2):
pubmed: 33670657
Int J Pediatr Otorhinolaryngol. 2020 Nov;138:110145
pubmed: 32499073
Ir J Med Sci. 2021 Jun 18;:
pubmed: 34145548
Front Immunol. 2021 Mar 23;12:582166
pubmed: 33833750
BMC Pediatr. 2020 Dec 23;20(1):562
pubmed: 33353540
Front Public Health. 2020 Dec 16;8:604089
pubmed: 33392141
Pediatr Emerg Care. 2021 Aug 1;37(8):427-434
pubmed: 34074990
Braz J Otorhinolaryngol. 2020 May - Jun;86(3):273-280
pubmed: 32371055
J Laryngol Otol. 2021 Feb;135(2):117-124
pubmed: 33612142
Otolaryngol Head Neck Surg. 2021 Jun;164(6):1208-1213
pubmed: 33138717
Isr J Health Policy Res. 2020 Oct 20;9(1):53
pubmed: 33081834
Am J Emerg Med. 2021 Nov;49:142-147
pubmed: 34111834
J Clin Med. 2021 Jun 27;10(13):
pubmed: 34199138
Otol Neurotol. 2020 Oct;41(9):1175-1181
pubmed: 32925833
Pediatr Infect Dis J. 2020 Dec;39(12):e423-e427
pubmed: 32773660
Clin Infect Dis. 2006 Dec 1;43(11):1417-22
pubmed: 17083014
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
Ann Otol Rhinol Laryngol. 2021 May;130(5):520-527
pubmed: 32911957
Cochrane Database Syst Rev. 2017 Sep 07;9:CD004417
pubmed: 28881007
Front Cell Infect Microbiol. 2021 Nov 01;11:768377
pubmed: 34790591
JAMA Otolaryngol Head Neck Surg. 2020 Oct 1;146(10):964-966
pubmed: 32701126
Medicine (Baltimore). 2021 Jul 9;100(27):e26583
pubmed: 34232205
Clin Infect Dis. 2015 Jan 1;60(1):1-9
pubmed: 25205769
Microbiol Spectr. 2016 Jun;4(3):
pubmed: 27337460
BMJ. 2020 Nov 13;371:m4125
pubmed: 33187951
Eur J Pediatr. 2007 Mar;166(3):223-8
pubmed: 16967296
Eur Arch Otorhinolaryngol. 2021 Jul 4;:
pubmed: 34218309
Otolaryngol Head Neck Surg. 2020 Jul;163(1):179-181
pubmed: 32423361
Laryngoscope. 2020 Nov;130(11):2690-2692
pubmed: 32602111
Int J Pediatr Otorhinolaryngol. 2021 Jun;145:110712
pubmed: 33887549
Am J Otolaryngol. 2020 May - Jun;41(3):102487
pubmed: 32336572
Laryngorhinootologie. 2021 Jun 15;:
pubmed: 34130328
Pediatr Infect Dis J. 2000 Feb;19(2):164-6
pubmed: 10694007
JAC Antimicrob Resist. 2020 Dec 08;2(4):dlaa105
pubmed: 34192254
Laryngoscope Investig Otolaryngol. 2020 Dec 16;6(1):129-136
pubmed: 33614941
Eur Arch Otorhinolaryngol. 2021 Jun;278(6):2133-2135
pubmed: 32876726
Otolaryngol Head Neck Surg. 2022 Jan;166(1):167-170
pubmed: 33940984
Otol Neurotol. 2021 Feb 1;42(2):217-226
pubmed: 33201081
Otolaryngol Head Neck Surg. 2021 Jan;164(1):67-73
pubmed: 32660367
Clin Infect Dis. 2008 Mar 15;46(6):815-23
pubmed: 18279042
Respir Res. 2020 Sep 29;21(1):252
pubmed: 32993656

Auteurs

Tal Marom (T)

Department of Otolaryngology-Head and Neck Surgery, Samson Assuta Ashdod University Hospital, Ben Gurion University Faculty of Health Sciences, Ashdod, Israel.

Jacob Pitaro (J)

Department of Otolaryngology-Head and Neck Surgery, Shamir Medical Center (formerly Assaf Harofeh Medical Center), Zerifin, Israel, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Udayan K Shah (UK)

Pediatric Otolaryngology, Delaware Valley, and Enterprise Chief of Credentialing, Nemours Children's Health System, Wilmington, DE, United States.
Departments of Otolaryngology-Head & Neck Surgery and Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.

Sara Torretta (S)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Paola Marchisio (P)

Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Ayan T Kumar (AT)

Department of Otolaryngology-Head & Neck Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.

Patrick C Barth (PC)

Departments of Otolaryngology-Head & Neck Surgery and Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.
Pediatric Otolaryngology, Delaware Valley Nemours Children's Health System, Wilmington, DE, United States.

Sharon Ovnat Tamir (SO)

Department of Otolaryngology-Head and Neck Surgery, Samson Assuta Ashdod University Hospital, Ben Gurion University Faculty of Health Sciences, Ashdod, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH